Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 189

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Rational Design and Synthesis of Novel Dual PROTACs for Simultaneous Degradation of EGFR and PARP

Open access
Zheng, Mengzhu, Huo, Junfeng, Gu, Xiaoxia, Wang, Yali, Wu, Canrong, Zhang, Qingzhe, Wang, Wang, Liu, Yang, Liu, Yu, Zhou, Xuechen, Chen, Lixia, Zhou, Yirong, Li, Hua·2021·Journal of Medicinal Chemistry

Abstract

Inspired by the success of dual-targeting drugs, especially bispecific antibodies, we propose to combine the concept of proteolysis targeting chimera (PROTAC) and dual targeting to design and synthesize dual PROTAC molecules with the function of degrading two completely different types of targets simultaneously. A library of novel dual-targeting PROTAC molecules has been rationally designed and prepared. A convergent synthetic strategy has been utilized to achieve high synthetic efficiency. These dual PROTAC structures are characterized using trifunctional natural amino acids as star-type core linkers to connect two independent inhibitors and E3 ligands together. In this study, gefitinib, olaparib, and CRBN or VHL E3 ligands were used as substrates to synthesize novel dual PROTACs. They successfully degraded both the epidermal growth factor receptor (EGFR) and poly(ADP-ribose) polymerase (PARP) simultaneously in cancer cells. Being the first successful example of dual PROTACs, this technique will greatly widen the range of application of the PROTAC method and open up a new field for drug discovery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.1c00649

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 189

Metadata

Authors
Zheng, M., Huo, J., Gu, X., Wang, Y., Wu, C., Zhang, Q., Wang, W., Liu, Y., Liu, Y., Zhou, X., Chen, L., Zhou, Y., & Li, H.
Venue
Journal of Medicinal Chemistry
Published
2021-05-26
Volume
64
Issue
11
Pages
7839-7852
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W3165173500
Cited by
189
References
7
FWCI
8.45
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rational Design and Synthesis of Novel Dual PROTACs for Simultaneous Degradation of EGFR and PARP. https://app.cochat.ai/papers/10.1021/acs.jmedchem.1c00649
The paper
Zheng, M., Huo, J., Gu, X., Wang, Y., Wu, C., Zhang, Q., Wang, W., Liu, Y., Liu, Y., Zhou, X., Chen, L., Zhou, Y., & Li, H. (2021). Rational Design and Synthesis of Novel Dual PROTACs for Simultaneous Degradation of EGFR and PARP. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.1c00649

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.